Perrigo Co PLC (PRGO): EBITDA
-$784.70M
Year ended 2025-12-31
-$1.21B
Trailing 12 months to 2026-06-27
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$784.70M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $438.80M | -14.2% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $511.40M | +22.5% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $417.50M | -42.2% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $722.60M | +11.2% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $650.00M | +13.8% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $571.20M | n/c | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $660.10M | -36.7% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $1.04B | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$1.54B | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2015-06-27 and 2016-12-31. | |||
| 2015-06-27 | $931.20M | +19.8% | 2018-03-01, From 2014-06-29 |
| 2014-06-28 | $777.50M | n/c | 2017-05-22, From 2013-06-30 |
| 2013-06-29 | $839.30M | +19.1% | 2015-08-13, From 2012-07-01 |
| 2012-06-30 | $704.50M | n/a | 2014-08-14, From 2011-06-26 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$784.70M | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$388.64M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $557.24M | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $588.82M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $489.04M | -15.8% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.58B | +8.9% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$655.26M | n/m |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $3.02B | +7.4% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $905.75M | n/m |
Compare PRGO, JAZZ, ALNY, ONC side by side · Screen every company in Pharmaceutical Preparations ↗